TIANAN MEDICARE (00383) announced its annual performance, with a net profit attributable to shareholders of 28.773 million Hong Kong dollars, an increase of 96.03% year-on-year.

TIANAN MEDICARE (00383) announces its annual results for the year ending on December 31, 2024, with revenue of HK$1.627 billion, a year-on-year increase of 3.72%; net profit attributable to shareholders of HK$287.73 million, a year-on-year increase of 96.03%; earnings per share of HK$0.265, proposing a final dividend of HK$0.20 per share. It is reported that the increase in net profit attributable to shareholders is mainly due to the increase in operating income from the medical division; reduced borrowing costs in China, although there is an increase in fair value losses of certain invested properties; an increase in foreign exchange losses; write-offs and provisions related to trade receivables from medical insurance settlements; and offsetting net losses related to the closure of the comprehensive outpatient clinic in Nanjing, China.